RESILIENT PHARMA LTD
Significant control: Garry Laverty (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Resilient Pharma Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
RESILIENT PHARMA LTD is an active private limited company (company number NI701299) incorporated on 4 September 2023, registered in Magherafelt. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 September 2025, showing net assets of £1. Net assets were unchanged on the prior period.
By net assets it sits in the lower half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Dr Garry Laverty
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 4 September 20233 yrs ago
- Next accounts due
- 30 June 2027in 250 days
- Confirmation statement due
- 18 September 2027in 330 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £1 | — | — | — | — | — | — |
| 30 September 2024 | £1 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £1 at 30 September 2025
- Incorporated two to five years agoIncorporated 4 September 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 330 days
- Next accounts duein 250 days
- Accounts period endNet assets £1 · dormant accounts
- Accounts period endNet assets £1 · dormant accounts
- Incorporated
Similar companies in Belfast
- BUZZ BIOLABS LTD.Ballymoney · inc. Jul 2023
- BDIC MEDTECH LIMITEDBelfast · inc. Jun 2023
- VRRX THERAPEUTICS PVT LTDBelfast · inc. Dec 2023
- ANTIGENESIS BIOLOGICS LTDDownpatrick · inc. Feb 2024
- GRAN LAB LIMITEDBelfast · inc. Mar 2024
- SONAS PHARMACEUTICALS (N.I.) LIMITEDOmagh · inc. Apr 2024
All companies incorporated on 4 September 2023 · in Sept 2023.
Reminders for RESILIENT PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.